The MHRA has been approved adrenaline (epinephrine) nasal spray (EURneffy) to be used for the emergency treatment of serious allergic reactions, known as anaphylaxis.
As we enter the second half of 2025, Brevia Health has collected and analysed data on parliamentary discussions surrounding the leading diseases in the UK.
The Government published its 10-Year Health Plan for England, Fit for the Future, on Thursday 3 July 2025.
In June 2025, dementia and Alzheimer’s disease took centre stage with a surge in parliamentary interest aligned with national awareness campaigns.
As part of his new responsibilities, he will advise ministers and help drive forward the Government’s vision for health and social care.
In March 2025, data from our Tracker highlighted an awareness month that had a notable impact in the UK Parliament. Mentions of brain tumours by MPs saw a significant uptick.
The Government announced on 13 March 2025 that NHS England will be abolished. A decision of this significance at a time of high waiting lists for patients is a bold step by the Prime Minister and one that poses major challenges.
February 2025 was a month marked by World Cancer Day, which sparked a significant increase in discussions around cancer awareness and treatment in the UK Parliament.
Over the past five years, Brevia Health’s Disease Profile Tracker reveals an interesting and consistent pattern: a drop in the discussion of the leading diseases every January. This coincides with the lack of significant advocacy campaigns taking place in January compared to other months.
The Government’s long-term mission to build an NHS fit for the future begins with addressing waiting lists. The Plan for Change outlines steps to return to NHS performance standards and improve access to services.
